Systems-level interference strategies to decipher host factors involved in bacterial pathogen interaction: from RNAi to CRISPRi

Current Opinion in Microbiology

Volumn 39, Issue , 2017, Pages 34-41

  Québatte, Maxime ^a   Dehio, Christoph ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BACTERIAL INFECTION; BACTERIUM; CRISPR CAS SYSTEM; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; PATHOGENICITY; PROCEDURES; RNA INTERFERENCE; SYSTEMS BIOLOGY;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; CRISPR-CAS SYSTEMS; HOST-PATHOGEN INTERACTIONS; HUMANS; RNA INTERFERENCE; SYSTEMS BIOLOGY;

EID: 85028346720     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2017.08.002     Document Type: Review

References (80)

1. Ventola, C.L., The antibiotic resistance crisis: part 1: causes and threats. P T 40 (2015), 277–283.
2. Navratil, V., de Chassey, B., Combe, C.R., Lotteau, V., When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases. BMC Syst Biol, 5, 2011, 13.
3. Markowetz, F., How to understand the cell by breaking it: network analysis of gene perturbation screens. PLoS Comput Biol, 6, 2010, e1000655.
4. Mohr, S.E., Smith, J.A., Shamu, C.E., Neumuller, R.A., Perrimon, N., RNAi screening comes of age: improved techniques and complementary approaches. Nat Rev Mol Cell Biol 15 (2014), 591–600.
5. Zhang, X.D., An effective method for controlling false discovery and false nondiscovery rates in genome-scale RNAi screens. J Biomol Screen 15 (2010), 1116–1122.
6. Campeau, E., Gobeil, S., RNA interference in mammals: behind the screen. Brief Funct Genomics 10 (2011), 215–226.
7. Perreira, J.M., Meraner, P., Brass, A.L., Functional genomic strategies for elucidating human–virus interactions: will CRISPR knockout RNAi and haploid cells?. Adv Virus Res 94 (2016), 1–51.
8. Panda, D., Cherry, S., A genome-wide RNAi screening method to discover novel genes involved in virus infection. Methods 91 (2015), 75–81.
9. Savidis, G., McDougall, W.M., Meraner, P., Perreira, J.M., Portmann, J.M., Trincucci, G., John, S.P., Aker, A.M., Renzette, N., Robbins, D.R., et al. Identification of Zika virus and dengue virus dependency factors using functional genomics. Cell Rep 16 (2016), 232–246.
10. Ramage, H., Cherry, S., Virus–host interactions: from unbiased genetic screens to function. Annu Rev Virol 2 (2015), 497–524.
11. Friedrich, A., Pechstein, J., Berens, C., Luhrmann, A., Modulation of host cell apoptotic pathways by intracellular pathogens. Curr Opin Microbiol 35 (2017), 88–99.
12. Di Russo Case, E., Samuel, J.E., Contrasting lifestyles within the host cell. Microbiol Spectr, 4, 2016.
13. Kreibich, S., Hardt, W.D., Experimental approaches to phenotypic diversity in infection. Curr Opin Microbiol 27 (2015), 25–36.
14. Eicher, S.C., Dehio, C., Systems-level analysis of host–pathogen interaction using RNA interference. Nat Biotechnol 30 (2013), 308–313.
15. Rocheleau, C.E., Downs, W.D., Lin, R., Wittmann, C., Bei, Y., Cha, Y.H., Ali, M., Priess, J.R., Mello, C.C., Wnt signaling and an APC-related gene specify endoderm in early C. elegans embryos. Cell 90 (1997), 707–716.
16. Whitehurst, A.W., Bodemann, B.O., Cardenas, J., Ferguson, D., Girard, L., Peyton, M., Minna, J.D., Michnoff, C., Hao, W., Roth, M.G., et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 446 (2007), 815–819.
17. Fedorov, Y., King, A., Anderson, E., Karpilow, J., Ilsley, D., Marshall, W., Khvorova, A., Different delivery methods — different expression profiles. Nat Methods, 2, 2005, 241.
18. Meng, Z., Lu, M., RNA interference-induced innate immunity, off-target effect, or immune adjuvant?. Front Immunol, 8, 2017, 331.
19. Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G., Linsley, P.S., Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21 (2003), 635–637.
20. Jackson, A.L., Linsley, P.S., Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9 (2010), 57–67.
21. Singh, S., Wu, X., Ljosa, V., Bray, M.A., Piccioni, F., Root, D.E., Doench, J.G., Boehm, J.S., Carpenter, A.E., Morphological profiles of RNAi-induced gene knockdown are highly reproducible but dominated by seed effects. PLOS ONE, 10, 2015, e0131370.
22. Franceschini, A., Meier, R., Casanova, A., Kreibich, S., Daga, N., Andritschke, D., Dilling, S., Ramo, P., Emmenlauer, M., Kaufmann, A., et al. Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc Natl Acad Sci U S A 111 (2014), 4548–4553 This systems-level study describe how advantage can be taken from analyzing off-target effects from a multi-pathogen siRNA screen to design synthetic microRNA-like moleculares with promising therapeutic applications.
23. Ramo, P., Drewek, A., Arrieumerlou, C., Beerenwinkel, N., Ben-Tekaya, H., Cardel, B., Casanova, A., Conde-Alvarez, R., Cossart, P., Csucs, G., et al. Simultaneous analysis of large-scale RNAi screens for pathogen entry. BMC Genomics, 15, 2014, 1162.
24. Schmich, F., Szczurek, E., Kreibich, S., Dilling, S., Andritschke, D., Casanova, A., Low, S.H., Eicher, S., Muntwiler, S., Emmenlauer, M., et al. gespeR: a statistical model for deconvoluting off-target-confounded RNA interference screens. Genome Biol, 16, 2015, 220.
25. Alkan, F., Wenzel, A., Palasca, O., Kerpedjiev, P., Rudebeck, A.F., Stadler, P.F., Hofacker, I.L., Gorodkin, J., RIsearch2: suffix array-based large-scale prediction of RNA-RNA interactions and siRNA off-targets. Nucleic Acids Res, 45, 2017, e60.
26. Riba, A., Emmenlauer, M., Chen, A., Sigoillot, F., Cong, F., Dehio, C., Jenkins, J., Zavolan, M., Explicit modeling of siRNA-dependent on- and off-target repression improves the interpretation of screening results. Cell Syst 4 (2017), 182–193 e184 This paper presents an encouraging solution to model siRNA off-target efficacy, which should greatly improves RNAi screens interpretation.
27. Gu, S., Zhang, Y., Jin, L., Huang, Y., Zhang, F., Bassik, M.C., Kampmann, M., Kay, M.A., Weak base pairing in both seed and 3′ regions reduces RNAi off-targets and enhances si/shRNA designs. Nucleic Acids Res 42 (2014), 12169–12176.
28. Jackson, A.L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J.M., Lim, L., Karpilow, J., Nichols, K., et al. Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing. RNA 12 (2006), 1197–1205.
29. Li, C., Liu, Z., Yang, F., Liu, W., Wang, D., Dong, E., Wang, Y., Wu, C.I., Lu, X., siRNAs with decreased off-target effect facilitate the identification of essential genes in cancer cells. Oncotarget 6 (2015), 21603–21613.
30. Zagalak, J.A., Menzi, M., Schmich, F., Jahns, H., Dogar, A.M., Wullschleger, F., Towbin, H., Hall, J., Properties of short double-stranded RNAs carrying randomized base pairs: toward better controls for RNAi experiments. RNA 21 (2015), 2132–2142.
31. Hannus, M., Beitzinger, M., Engelmann, J.C., Weickert, M.T., Spang, R., Hannus, S., Meister, G., siPools: highly complex but accurately defined siRNA pools eliminate off-target effects. Nucleic Acids Res 42 (2014), 8049–8061.
32. Zhu, J., Davoli, T., Perriera, J.M., Chin, C.R., Gaiha, G.D., John, S.P., Sigiollot, F.D., Gao, G., Xu, Q., Qu, H., et al. Comprehensive identification of host modulators of HIV-1 replication using multiple orthologous RNAi reagents. Cell Rep 9 (2014), 752–766.
33. Alagia, A., Eritja, R., siRNA and RNAi optimization. Wiley Interdisc Rev RNA 7 (2016), 316–329.
34. Fennell, M., Xiang, Q., Hwang, A., Chen, C., Huang, C.H., Chen, C.C., Pelossof, R., Garippa, R.J., Impact of RNA-guided technologies for target identification and deconvolution. J Biomol Screen 19 (2014), 1327–1337.
35. Siebourg-Polster, J., Mudrak, D., Emmenlauer, M., Ramo, P., Dehio, C., Greber, U., Frohlich, H., Beerenwinkel, N., NEMix: single-cell nested effects models for probabilistic pathway stimulation. PLoS Comput Biol, 11, 2015, e1004078.
36. Liberali, P., Snijder, B., Pelkmans, L., Single-cell and multivariate approaches in genetic perturbation screens. Nat Rev Genet 16 (2015), 18–32.
37. Snijder, B., Sacher, R., Ramo, P., Liberali, P., Mench, K., Wolfrum, N., Burleigh, L., Scott, C.C., Verheije, M.H., Mercer, J., et al. Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol, 8, 2012, 579.
38. Boutros, M., Heigwer, F., Laufer, C., Microscopy-based high-content screening. Cell 163 (2015), 1314–1325.
39. Gunkel, M., Beil, N., Beneke, J., Reymann, J., Erfle, H., Fluorescence microscopy-based RNA interference screening. Methods Mol Biol 1251 (2015), 59–66.
40. Rohban, M.H., Singh, S., Wu, X., Berthet, J.B., Bray, M.A., Shrestha, Y., Varelas, X., Boehm, J.S., Carpenter, A.E., Systematic morphological profiling of human gene and allele function via Cell Painting. Elife, 6, 2017.
41. Grys, B.T., Lo, D.S., Sahin, N., Kraus, O.Z., Morris, Q., Boone, C., Andrews, B.J., Machine learning and computer vision approaches for phenotypic profiling. J Cell Biol 216 (2017), 65–71.
42. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339 (2013), 819–823.
43. Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., Doudna, J., RNA-programmed genome editing in human cells. Elife, 2, 2013, e00471.
44. Shalem, O., Sanjana, N.E., Hartenian, E., Shi, X., Scott, D.A., Mikkelsen, T.S., Heckl, D., Ebert, B.L., Root, D.E., Doench, J.G., et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343 (2014), 84–87.
45. Wang, T., Wei, J.J., Sabatini, D.M., Lander, E.S., Genetic screens in human cells using the CRISPR-Cas9 system. Science 343 (2014), 80–84.
46. Anderson, E.M., Haupt, A., Schiel, J.A., Chou, E., Machado, H.B., Strezoska, Z., Lenger, S., McClelland, S., Birmingham, A., Vermeulen, A., et al. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity. J Biotechnol 211 (2015), 56–65.
47. Kleinstiver, B.P., Pattanayak, V., Prew, M.S., Tsai, S.Q., Nguyen, N.T., Zheng, Z., Joung, J.K., High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529 (2016), 490–495.
48. Tsai, S.Q., Wyvekens, N., Khayter, C., Foden, J.A., Thapar, V., Reyon, D., Goodwin, M.J., Aryee, M.J., Joung, J.K., Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32 (2014), 569–576.
49. Doench, J.G., Hartenian, E., Graham, D.B., Tothova, Z., Hegde, M., Smith, I., Sullender, M., Ebert, B.L., Xavier, R.J., Root, D.E., Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol 32 (2014), 1262–1267.
50. Xu, H., Xiao, T., Chen, C.H., Li, W., Meyer, C.A., Wu, Q., Wu, D., Cong, L., Zhang, F., Liu, J.S., et al. Sequence determinants of improved CRISPR sgRNA design. Genome Res 25 (2015), 1147–1157.
51. Cameron, P., Fuller, C.K., Donohoue, P.D., Jones, B.N., Thompson, M.S., Carter, M.M., Gradia, S., Vidal, B., Garner, E., Slorach, E.M., et al. Mapping the genomic landscape of CRISPR-Cas9 cleavage. Nat Methods, 2017.
52. Frock, R.L., Hu, J., Meyers, R.M., Ho, Y.J., Kii, E., Alt, F.W., Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat Biotechnol 33 (2015), 179–186.
53. Koo, T., Lee, J., Kim, J.S., Measuring and reducing off-target activities of programmable nucleases including CRISPR-Cas9. Mol Cell 38 (2015), 475–481.
54. Wang, X., Wang, Y., Wu, X., Wang, J., Wang, Y., Qiu, Z., Chang, T., Huang, H., Lin, R.J., Yee, J.K., Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol 33 (2015), 175–178.
55. Morgens, D.W., Wainberg, M., Boyle, E.A., Ursu, O., Araya, C.L., Tsui, C.K., Haney, M.S., Hess, G.T., Han, K., Jeng, E.E., et al. Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens. Nat Commun, 8, 2017, 15178.
56. Agrotis, A., Ketteler, R., A new age in functional genomics using CRISPR/Cas9 in arrayed library screening. Front Genet, 6, 2015, 300.
57. Shalem, O., Sanjana, N.E., Zhang, F., High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet 16 (2015), 299–311.
58. Gilbert, L.A., Larson, M.H., Morsut, L., Liu, Z., Brar, G.A., Torres, S.E., Stern-Ginossar, N., Brandman, O., Whitehead, E.H., Doudna, J.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154 (2013), 442–451 Landmark publication demonstrating a panel of CRISPRi approaches that enable gene repression and activation with minimal off-target effects in human cells.
59. Gilbert, L.A., Horlbeck, M.A., Adamson, B., Villalta, J.E., Chen, Y., Whitehead, E.H., Guimaraes, C., Panning, B., Ploegh, H.L., Bassik, M.C., et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159 (2014), 647–661 First report of a genome-wide CRISRPi/a screen, using cholera/diphtheria toxicity towards host cells as a selection.
60. Konermann, S., Brigham, M.D., Trevino, A.E., Joung, J., Abudayyeh, O.O., Barcena, C., Hsu, P.D., Habib, N., Gootenberg, J.S., Nishimasu, H., et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517 (2015), 583–588.
61. McDonough, J.A., Newton, H.J., Klum, S., Swiss, R., Agaisse, H., Roy, C.R., Host pathways important for Coxiella burnetii infection revealed by genome-wide RNA interference screening. mBio 4 (2013), e00606–e00612.
62. Kuhbacher, A., Emmenlauer, M., Ramo, P., Kafai, N., Dehio, C., Cossart, P., Pizarro-Cerda, J., Genome-wide siRNA screen identifies complementary signaling pathways involved in Listeria infection and reveals different actin nucleation mechanisms during Listeria cell invasion and actin comet tail formation. mBio 6 (2015), e00598–e00615.
63. Milivojevic, M., Dangeard, A.S., Kasper, C.A., Tschon, T., Emmenlauer, M., Pique, C., Schnupf, P., Guignot, J., Arrieumerlou, C., ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria. PLoS Pathog, 13, 2017, e1006224 This study identified the host proteins ALPK1, TIFA and TRAF6 as sequential activators of the transcription factor NF-κB, which regulates the production of chemokines in response to infection by the pathogens Shigella flexneri, Salmonella typhimurium and Neisseria meningitidis.
64. Kreibich, S., Emmenlauer, M., Fredlund, J., Ramo, P., Munz, C., Dehio, C., Enninga, J., Hardt, W.D., Autophagy proteins promote repair of endosomal membranes damaged by the Salmonella type three secretion system 1. Cell Host Microbe 18 (2015), 527–537 This study presents the results of an RNAi screen, which implicates autophagy in the maintenance of the Salmonella containing vacuole and in eliminating cytosolic Salmonella. The results support a general role for autophagy in maintaining endosomal membrane integrity.
65. Andritschke, D., Dilling, S., Emmenlauer, M., Welz, T., Schmich, F., Misselwitz, B., Ramo, P., Rottner, K., Kerkhoff, E., Wada, T., et al. A genome-wide siRNA screen implicates Spire1/2 in SipA-driven Salmonella Typhimurium host cell invasion. PLOS ONE, 11, 2016, e0161965.
66. Thornbrough, J.M., Gopinath, A., Hundley, T., Worley, M.J., Human genome-wide RNAi screen for host factors that facilitate Salmonella invasion reveals a role for potassium secretion in promoting internalization. PLOS ONE, 11, 2016, e0166916.
67. Sun, J., Katz, S., Dutta, B., Wang, Z., Fraser, I.D., Genome-wide siRNA screen of genes regulating the LPS-induced TNF-alpha response in human macrophages. Sci Data, 4, 2017, 170007.
68. Santhakumar, D., Forster, T., Laqtom, N.N., Fragkoudis, R., Dickinson, P., Abreu-Goodger, C., Manakov, S.A., Choudhury, N.R., Griffiths, S.J., Vermeulen, A., et al. Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Proc Natl Acad Sci U S A 107 (2010), 13830–13835.
69. Eulalio, A., Mano, M., Dal Ferro, M., Zentilin, L., Sinagra, G., Zacchigna, S., Giacca, M., Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492 (2012), 376–381.
70. Maudet, C., Mano, M., Sunkavalli, U., Sharan, M., Giacca, M., Forstner, K.U., Eulalio, A., Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection. Nat Commun, 5, 2014, 4718.
71. Sheahan, K.L., Isberg, R.R., Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity. mBio, 6, 2015 e02023-02014 Using an elegant combination of fluorescence resonance energy transfer (FRET), this publication reports the screen a pooled shRNA library for host proteins required for Yersinia effector translocation.
72. Koike-Yusa, H., Li, Y., Tan, E.P., Velasco-Herrera, M.del.C., Yusa, K., Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 32 (2014), 267–273.
73. Virreira Winter, S., Zychlinsky, A., Bardoel, B.W., Genome-wide CRISPR screen reveals novel host factors required for Staphylococcus aureus alpha-hemolysin-mediated toxicity. Sci Rep, 6, 2016, 24242.
74. Blondel, C.J., Park, J.S., Hubbard, T.P., Pacheco, A.R., Kuehl, C.J., Walsh, M.J., Davis, B.M., Gewurz, B.E., Doench, J.G., Waldor, M.K., CRISPR/Cas9 screens reveal requirements for host cell sulfation and fucosylation in bacterial type III secretion system-mediated cytotoxicity. Cell Host Microbe 20 (2016), 226–237 Using genome-wide CRISPR screens, this study reveals that different host factors are required for the cytotoxicity mediated by the two distinct type III secretion systems of Vibrio parahaemolyticus.
75. Schmidt, T., Schmid-Burgk, J.L., Hornung, V., Synthesis of an arrayed sgRNA library targeting the human genome. Sci Rep, 5, 2015, 14987.
76. Kelley, M.L., Strezoska, Z., He, K., Vermeulen, A., Smith, A., Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing. J Biotechnol 233 (2016), 74–83.
77. Tan, J., Martin, S.E., Validation of synthetic CRISPR reagents as a tool for arrayed functional genomic screening. PLOS ONE, 11, 2016, e0168968.
78. Buchser, W., Collins, M., Garyantes, T., Guha, R., Haney, S., Lemmon, V., Li, Z., Trask, O.J., Assay development guidelines for image-based high content screening, high content analysis and high content imaging. Sittampalam, G.S., Coussens, N.P., Brimacombe, K., Grossman, A., Arkin, M., Auld, D., Austin, C., Baell, J., Bejcek, B., Chung, T.D.Y., et al. (eds.) Assay Guidance Manual, 2004.
79. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136 (2009), 215–233.
80. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D.A., Horvath, P., CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.